Indian tech stocks experienced a sharp decline Friday, mirroring a significant drop in global IT giant Accenture due to weaker-than-expecte...

ICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...

Brokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...

Zerodha CEO Nithin Kamath lost a ₹2.5 lakh fitness bet to employee Rohit Agarwala, who successfully shed 30 kg in a year. Agarwala's transf...

The shares of the fintech platform had made a solid market debut in December, 2024, listing with nearly 59% premium over the IPO price at R...

Rappid Valves (India), a precision-engineered industrial and marine valve manufacturer, has secured strategic orders aggregating INR 29.86 ...

Formula 1 is focusing on India as a key market. The sport's chief executive sees potential for a return to India. Adani Group is actively w...

Yes Bank shares extended gains for a fourth straight session, rising as much as 6.5%. Technical indicators and improving sentiment supporte...

A young woman achieved significant weight loss without gyms or crash diets. She focused on walking 10,000 steps daily and eating home-cooke...

India saw a massive surge in battery energy storage capacity in early 2026. The country added 4.6 gigawatt-hours in the first three months,...

Manufacturing companies saw sales jump 14.5 percent in the fourth quarter of 2025-26. Automobiles, electrical machinery, and non-ferrous me...

Tata Consultancy Services will book a $70 million charge in the first quarter of FY27. This follows the US Supreme Court's decision not to ...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Zee Entertainment Enterprises' shares rose after its board approved raising at least Rs 2,300 crore to fund strategic initiatives and bolst...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

Quick commerce firm Zepto's promoters will not dilute equity in its upcoming IPO, which aims to raise Rs 8,010 crore via fresh issue and an...

UBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...